118 related articles for article (PubMed ID: 2436781)
1. Thyroxine-binding globulin as a marker of liver tumors.
Terui S; Moriya Y; Yamamoto H; Koyama Y
Cancer Detect Prev; 1987; 10(5-6):371-8. PubMed ID: 2436781
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of thyroxine-binding globulin (TBG) as a marker of liver tumors.
Terui S
Eur J Nucl Med; 1984; 9(3):121-4. PubMed ID: 6201364
[TBL] [Abstract][Full Text] [Related]
3. [Thyroxine-binding globulin--not a tumor marker of hepatocellular cancer].
Sieg A; Schönpflug A; Seitz HK; Kommerell B
Z Gastroenterol; 1991 Mar; 29(3):101-4. PubMed ID: 1647573
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
Shi X; Zhou Y; Xia L
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients.
Torzilli G; Makuuchi M; Ferrero A; Takayama T; Hui AM; Abe H; Inoue K; Nakahara K
Hepatogastroenterology; 2002; 49(45):740-5. PubMed ID: 12063982
[TBL] [Abstract][Full Text] [Related]
6. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
[TBL] [Abstract][Full Text] [Related]
8. [Carcino-fetal antigens].
Endo Y
Nihon Rinsho; 1996 Jun; 54(6):1499-504. PubMed ID: 8691600
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
Weber P; Weberová D; Martínek K
Neoplasma; 1988; 35(5):605-13. PubMed ID: 2464143
[TBL] [Abstract][Full Text] [Related]
10. Plasma carcinoembryonic antigen in the diagnosis and management of patients with hepatocellular carcinoma.
Melia WM; Johnson PJ; Carter S; Munro-Neville A; Williams R
Cancer; 1981 Aug; 48(4):1004-8. PubMed ID: 6168358
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
12. Thyroxine-binding globulin and thyroid hormones after resection of hepatocellular carcinoma.
Nagasue N; Ohmori H; Hashimoto N; Tachibana M; Kubota H; Uchida M; Yu L
Am J Gastroenterol; 1997 Jul; 92(7):1187-9. PubMed ID: 9219796
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of examination of some tumor markers in diagnostics of liver cancer.
Snarska J; Szajda SD; Puchalski Z; Szmitkowski M; Chabielska E; Kaminski F; Zwierz P; Zwierz K
Hepatogastroenterology; 2006; 53(68):271-4. PubMed ID: 16608038
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.
Barroso A; Alpert E
Lab Res Methods Biol Med; 1983; 7():153-7. PubMed ID: 6194396
[No Abstract] [Full Text] [Related]
15. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
16. [Tumor markers of hepatocellular carcinoma with special reference to diagnostic efficacy of combination of these markers and relation to its stages].
Sawabu N; Wakabayashi T; Ozaki K; Toya D; Yoneshima M
Gan No Rinsho; 1983 May; 29(6):672-7. PubMed ID: 6192267
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the plasma levels of alpha-1 fetoprotein and carcinoembryonic antigen in chronic liver diseases and malignant neoplasias (author's transl)].
Del Vecchio-Blanco C; Caporaso N; Balzano A; Grande R
Quad Sclavo Diagn; 1977 Sep; 13(3):288-97. PubMed ID: 77537
[TBL] [Abstract][Full Text] [Related]
18. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
20. Differential tumor markers and hepatitis markers profile in liver tumors.
Khalifa A; Mady EA; Abadeer N; Kamal A
Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
